Impressive Rally in Diagnostics and Tools Stocks
The NASDAQ rally is beginning to fade now up only 17 points after hitting a high of 3510 at 10 am EDT. However many Life Science Tools and Diagnostics stocks are having a strong day. We recently featured 3 micro-cap diagnostics stocks in the $50M market cap range which were positioned for growth and all three are up considerably with BG Medicine (NASDAQ:BGMD) up 14% and Vermillion (VRML) up 5.84% -big moves today on good volume.
Our Diagnostics and Tools Focus stocks show a lot of green with the following 1.5% + winners:
Abaxis (NASDAQ:ABAX), CardioVascular Sciences (NASDAQ:CSII), Exact Sciences (NASDAQ:EXAS), Illumina (ILMN $71.60), Neogen (NEOG)- all time high at $56+, Quidel (NASDAQ:QDEL) and as previously mentioned BGMD and VRML. Illumina is up 30% YTD and approaching its 2011 high of $76.Genomic Health (NASDAQ:GHDX) is up 0.6% but at an all time high.
Many of these stocks are still at or near their 2013 highs but show resilience.
We will review fundamentals on diagnostics and tools stocks after all release of all Q1 earnings. Here is our 2012 metrics Summary from March 21, 2013.